Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CIMPASI-2).
Dermatol Ther (Heidelb)
; 13(1): 315-328, 2023 Jan.
Article
in En
| MEDLINE
| ID: mdl-36509889
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Clinical_trials
Aspects:
Patient_preference
Language:
En
Journal:
Dermatol Ther (Heidelb)
Year:
2023
Document type:
Article